Zymeworks ZYME
NASDAQ ZYME
$29.37 -0.53 (-1.77%)
As of: Sep 4, 2026 · 2:42 PM EDT

Zymeworks (ZYME) Interest & Investment Income (2021 - 2026)

Zymeworks (ZYME) posted Interest & Investment Income of -$486000.0 for Q1 2026, down 1575.86% sequentially from -$29000.0 in Q4 2025, and down 189.01% YoY from $546000.0 in Q1 2025.

Analysis

Zymeworks (ZYME) Interest & Investment Income (2021 - 2026) Analysis & Trends

Zymeworks has reported Interest & Investment Income for 4 years, with the latest figure at -$486000.0 in Q1 2026.

  • Quarterly Interest & Investment Income fell 189.01% year-over-year to -$486000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$159000.0 (down 112.06% YoY) and the FY2025 annual result came in at $873000.0, up 350.14% from the prior year.
  • Interest & Investment Income fell to -$486000.0 in Q1 2026 per ZYME's latest filing, from -$29000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.9 million in Q3 2024 and troughed at -$1.9 million in Q2 2023.
  • A 4-year average of $7230.8 and a median of -$29000.0 in 2025 frame the typical range for Interest & Investment Income.
  • The widest YoY moves for Interest & Investment Income: up 492.78% in 2024, down 255.69% in 2024.
  • Over 4 years, Interest & Investment Income stood at $1.7 million in 2023, then tumbled by 156.22% to -$953000.0 in 2024, then surged by 96.96% to -$29000.0 in 2025, then sank by 1575.86% to -$486000.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered -$486000.0, -$29000.0, and $290000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn - 35.58 Mn
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 5.13 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 10.98 Mn
10 Zymeworks 2.15 Bn 1.88 Bn - 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.29 Mn
Mar 31, 2026 2.71 Mn
Dec 31, 2025 2.98 Mn
Sep 30, 2025 3.53 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 3.42 Mn
Dec 31, 2024 4.08 Mn
Sep 30, 2024 4.79 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 5.92 Mn
Dec 31, 2023 5.05 Mn
Sep 30, 2023 5.03 Mn
Jun 30, 2023 4.83 Mn
Mar 31, 2023 4.81 Mn
Dec 31, 2022 1.73 Mn
Sep 30, 2022 1.13 Mn
Jun 30, 2022 436,000.00
Mar 31, 2022 302,000.00
Dec 31, 2021 296,000.00
Sep 30, 2021 340,000.00